T. Rowe Price Associates’s Medallia, Inc. MDLA Stock Holding History

T. Rowe Price Associates’s Portfolio MDLA Stock Details MDLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-39,258	Closed	-$1.33M	–	3106
2021 Q3	$1.33M	Buy	39,258 +300	+0.8%	+$10K	﹤0.01%	1901
2021 Q2	$1.31M	Buy	38,958 +2,700	+7%	+$77.6K	﹤0.01%	1936
2021 Q1	$1.01M	Buy	36,258 +6,676	+23%	+$248K	﹤0.01%	2040
2020 Q4	$983K	Buy	29,582 +14,381	+95%	+$459K	﹤0.01%	1947
2020 Q3	$417K	Buy	+15,201	New	+$461K	﹤0.01%	2166
2020 Q2	–	Sell	-1,012,683	Closed	-$20.3M	–	2556
2020 Q1	$20.3M	Sell	1,012,683 -595,174	-37%	-$16M	﹤0.01%	1074
2019 Q4	$50M	Buy	1,607,857 +1,198,048	+292%	+$35.4M	0.01%	912
2019 Q3	$11.2M	Buy	+409,809	New	+$14.5M	﹤0.01%	1270

T. Rowe Price Associates's MDLA Position: Q4 2021 in Review

T. Rowe Price Associates sold out of Medallia, Inc. (MDLA) in Q4 2021, closing a stake of 39,258 shares — an estimated $1.33M sold.

T. Rowe Price Associates first reported a position in MDLA in Q3 2019 and held it in 8 quarters. The position peaked at $50M in Q4 2019. 0 funds tracked by Wall St. Rank hold MDLA as of Q4 2021.

T. Rowe Price Associates reported no remaining Medallia, Inc. position as of Q4 2021 after selling out during the quarter.
T. Rowe Price Associates sold 39,258 Medallia, Inc. shares in Q4 2021, an estimated $1.33M.
T. Rowe Price Associates first reported a position in Medallia, Inc. in Q3 2019 and held it in 8 quarters.
T. Rowe Price Associates's Medallia, Inc. position peaked at $50M in Q4 2019.
0 funds tracked by Wall St. Rank held Medallia, Inc. as of Q4 2021.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.